Harding Loevner LP Walgreens Boots Alliance, Inc. Transaction History

Harding Loevner LP

$17.6 Billion
Q2 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$34.67 - $43.16 $34 - $43	-1 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$38.35 - $47.02 $83.3 Million - $102 Million	-2,172,141 Reduced 100.0%	1 $0
Q1 2020 May 15, 2020	SELL	$41.02 - $59.59 $167,033 - $242,650	-4,072 Reduced 0.19%	2,172,142 $99.4 Million
Q4 2019 Feb 14, 2020	SELL	$52.08 - $62.72 $14.7 Million - $17.7 Million	-282,337 Reduced 11.48%	2,176,214 $128 Million
Q3 2019 Nov 14, 2019	BUY	$49.29 - $58.06 $551,456 - $649,575	11,188 Added 0.46%	2,458,551 $136 Million
Q2 2019 Aug 14, 2019	SELL	$49.34 - $63.49 $1.71 Million - $2.19 Million	-34,570 Reduced 1.39%	2,447,363 $134 Million
Q1 2019 May 15, 2019	BUY	$59.79 - $74.43 $3.81 Million - $4.74 Million	63,659 Added 2.63%	2,481,933 $157 Million
Q4 2018 Feb 14, 2019	BUY	$65.26 - $85.69 $60.1 Million - $78.9 Million	920,481 Added 61.46%	2,418,274 $165 Million
Q3 2018 Nov 14, 2018	BUY	$60.76 - $73.81 $2.71 Million - $3.29 Million	44,559 Added 3.07%	1,497,793 $109 Million
Q2 2018 Aug 14, 2018	SELL	$59.7 - $68.0 $750,787 - $855,168	-12,576 Reduced 0.86%	1,453,234 $87.2 Million
Q1 2018 May 14, 2018	SELL	$65.43 - $80.27 $685,313 - $840,747	-10,474 Reduced 0.71%	1,465,810 $96.1 Million
Q4 2017 Feb 12, 2018	SELL	$64.48 - $76.95 $2.55 Million - $3.04 Million	-39,561 Reduced 2.61%	1,476,284 $107 Million
Q3 2017 Nov 14, 2017	SELL	$77.22 - $82.74 $103 Million - $110 Million	-1,328,362 Reduced 46.7%	1,515,845 $117 Million
Q3 2017 Nov 13, 2017	BUY	$77.22 - $82.74 $220 Million - $235 Million	2,844,207	2,844,207 $116 Million

Others Institutions Holding WBA

# of Institutions

1,073

Shares Held

512M

Call Options Held

19.7M

Put Options Held

24.4M

View Full List

About Walgreens Boots Alliance, Inc.

Ticker WBA
Exchange NASDAQ
Sector Healthcare
Industry Pharmaceutical Retailers
Shares Outstandng 864,812,992
Market Cap $7.77B
Description
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products...

More about WBA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harding Loevner LP, based on Form 13F filings with the SEC.

News

Stay updated on Harding Loevner LP with notifications on news.

Account